POINT Biopharma Global Overview

POINT Biopharma Global Operating Income

Operating Income for PNT.

Quarterly Operating Income

$-29626162.00

↑ 20.25% YoY

As of Sep 30, 2023

Annual Operating Income (TTM)

$107.77M

Trailing 12 months ending Sep 30, 2023

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin